Lenvatinib CAS: 417716-92-8

Product Parameters
Catalog No. BA17EQ
CAS.RN 417716-92-8
Molecular Formula C21H19ClN4O4
Molecular Weight 426.85 g/mol
Purity NLT 98%
Product Overview

Lenvatinib is a multi-target tyrosine kinase inhibitor widely used in the field of oncology treatment, particularly demonstrating good clinical efficacy in indications such as thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. As an active pharmaceutical ingredient (API), this product is suitable for all stages of drug development, process development, pilot-scale amplification, and commercial production, meeting the stringent requirements of pharmaceutical companies for high-quality starting materials. It is a preferred raw material for innovative drug development and generic drug production.

Applications
  • Oncology drug research and development and process development
  • Synthesis of drugs for indications such as thyroid cancer and renal cell carcinoma
  • Supply of raw materials for innovative and generic drugs
  • Custom synthesis of pharmaceutical intermediates
  • Process route optimization and scale-up production support
Quality & Supply Capability

English Name: Lenvatinib Properties: This product is a white to off-white solid with good chemical stability. Its molecular structure contains core functional groups such as phenyl and piperazine groups, meeting the physicochemical requirements of antitumor drug raw materials. Storage Recommendations: Store in a sealed, light-protected, and dry place, subject to the COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process service from laboratory sample supply to small-scale preparation, pilot-scale amplification, and customized batch production. We can flexibly formulate supply solutions according to customers' specific requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documents. Simultaneously, we have a professional technical support team that can assist customers in completing process development, route optimization, and project transformation from laboratory research and development to industrial production, ensuring stable product quality and meeting production needs at different stages.

Why Choose Bioncan

Focused on the field of anti-tumor active pharmaceutical ingredients (APIs), possessing extensive R&D and manufacturing experience. Full-scale supply capability, covering needs from sample production to commercial-scale mass production. Provides complete quality control documentation support, including COA, MSDS, HPLC, NMR, etc. Supports customized needs, flexibly addressing different customers' purity, packaging, and delivery requirements. Provides supporting process optimization and project scale-up technologies to help customers achieve efficient commercialization.

Intermediates of Lenvatinib
Catalog No. Product Name CAS
BA17EQ Lenvatinib API 417716-92-8
BK54X3 4-Chloro-7-methoxyquinoline-6-carboxamide 417721-36-9
BK4BX2 4-Amino-3-chlorophenol hydrochloride 52671-64-4
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting

For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 417716-92-8, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.